# Governance Notes

## Governance principle

This project treats AI as a governed clinical workflow component, not as an autonomous diagnostic authority.

The AI layer is intended to support clinician judgment by surfacing risk signals, synthesizing patient context, and presenting explainable recommendations. Clinical decisions remain with qualified clinicians and care teams.

## Key safety controls

Recommended governance and safety controls include:

- Human-in-the-loop review for diagnostic decisions
- Explainability requirements for AI-generated recommendations
- Traceability from recommendation to supporting evidence
- Monitoring for overdiagnosis and false positives
- Bias and subgroup performance review
- Model drift monitoring
- Feedback loops from clinician interaction data
- Clear escalation pathways for uncertainty
- Audit trails for AI-assisted outputs and clinical actions
- Governance checkpoints before scale-up

## Responsible AI considerations

The intervention should be evaluated not only for performance, but also for trustworthiness in the clinical workstream.

Important questions include:

- Does the AI output explain why a patient was flagged?
- Can a clinician inspect the underlying evidence?
- Does the system know when to defer or ask for review?
- Are recommendations aligned with accepted clinical criteria?
- Are false positives and false negatives monitored?
- Does the system reduce cognitive burden or add alert fatigue?
- Are subgroup differences measured and addressed?

## Operational hand-off

If validated, the intervention should be transitioned through a structured hand-off to clinical informatics, IT operations, quality, and relevant clinical stakeholders.

The hand-off package may include:

- Deployment documentation
- Integration protocols
- End-user training materials
- Monitoring dashboard definitions
- Escalation and support process
- Model update and retraining protocol
- Governance review checklist
- Phased support model for scale-up

## Why governance matters for Flow Research

Flow Research emphasizes fair value exchange between people and their agents. In a clinical setting, fair value exchange depends on trust, accountability, and verified usefulness.

A healthcare value engine should not reward mere activity. It should recognize high-quality contribution: earlier recognition, safer escalation, reduced friction, improved adherence, and outcomes that clinicians can trust.

Governance is how the workstream proves that the agent is doing useful work without creating invisible risk.
